Skip to search formSkip to main contentSkip to account menu

likopid

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
[Muramyldipeptide - based compounds in current medicine: focus on glucosaminylmuramyl dipeptide].
The role of immune mechanisms in the pathogenesis of almost all human diseases shown in recent decades, increase in antibiotic… 
2017
2017
[Cytopenias and their correction during antiviral therapy of chronic hepatitis C in patients with genotype 1].
The main reason for the ineffectiveness of antiviral therapy in patients with chronic hepatitis C that impedes full and adequate… 
2013
2013
[Likopid in complex treatment of oral dysbiosis].
The aim of the study was to assess likopid effectiveness in complex treatment of oral dysbiosis. The study included 76 patients… 
2011
2011
Single high-dose treatment with glucosaminyl-muramyl dipeptide is ineffective in treating ankylosing spondylitis
Earlier studies have shown that high doses of TNF-alpha increase apoptosis in human autoimmune T-cell clones. Based on these… 
2003
2003
[Experience in the use of immunomodulator likopid in ulcer disease].
We studied the effect of immunomodulator likopid on leukocytic immunity and duodenal ulcer (DU) course in 92 DU patients (70… 
2002
2002
The use of immunomodulator likopid in the combined treatment pulmonary tuberculosis
: Licopid is a synthetic analogue of a cell wall component of all bacteria. The monocytic macrophageal system is the main target… 
2002
2002
Likopid in the complex immunomodulating treatment of patients with sarcoidosis of the lung and intrathoracic lymph nodes
AIM To examine the functional status of the immune system in patients with lung and intrathoracic lymph nodes sarcoidosis and to… 
2002
2002
[Likopid in the complex immunomodulating treatment of patients with sarcoidosis of the lung and intrathoracic lymph nodes].
AIM To examine the functional status of the immune system in patients with lung and intrathoracic lymph nodes sarcoidosis and to… 
2001
2001
[Correction of immune response using purified staphylococcal toxoid and likopid in the secondary immunodeficiency induced by Coxsackie virus B3].
The action of immunomodulators, purified staphylococcal toxoid (PST) and lycopid, on secondary immunodeficiency state developing… 
1998
1998
[The clinico-immunological efficacy of the likopid treatment of chronic bronchitis patients].
AIM Elucidation of likopid effect on clinical and immunological pictures in patients with chronic bronchitis (CB). MATERIALS… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)